Viewing StudyNCT05031949


Ignite Creation Date: 2025-12-18 @ 9:15 AM
Ignite Modification Date: 2025-12-23 @ 10:50 PM
Study NCT ID: NCT05031949
Status: None
Last Update Posted: 2023-12-19 00:00:00
First Post: 2021-08-31 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma
Sponsor: None
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-10-30
Start Date Type: ACTUAL
Primary Completion Date: 2024-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-06-30
Completion Date Type: ESTIMATED
First Submit Date: 2021-08-31 00:00:00
First Submit QC Date: None
Study First Post Date: 2021-09-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-12-13 00:00:00
Last Update Post Date: 2023-12-19 00:00:00
Last Update Post Date Type: ACTUAL